文献速递外周动脉疾病

股下血管重建后WIfI 4期慢性肢体威胁性缺血患者大截肢的危险因素

Risk Factors for Major Amputation in Chronic Limb-Threatening Ischemia Patients Classified as Wound, Ischemia, and Foot Infection Stage 4 following Infrainguinal Revascularization.
PubMed 文献 · Ann Vasc Surg · 2023-03-02

回顾性多中心分析2015至2020年因慢性肢体威胁性缺血行股下血管重建的243例患者267条肢体,评估WIfI 4期患者保肢结局及大截肢危险因素。旁路手术组1年保肢率91.0%高于腔内治疗组68.6%(P<0.01);踝下P0、P1、P2组1年保肢率分别为91.8%、79.9%、53.1%(P<0.01)。多因素分析显示低血清白蛋白、充血性心力衰竭、高伤口分级、踝下P1-2及腔内治疗为需二次大截肢的独立危险因素。

要点

  • WIfI 4期患者股下腔内治疗后踝下P1-2者保肢率差
  • 旁路手术组1年保肢率91.0%高于腔内治疗组68.6%(P<0.01)
  • 低白蛋白、充血性心力衰竭、高伤口分级、踝下P1-2及腔内治疗为独立危险因素

核心结论

  • WIfI 4期慢性肢体威胁性缺血患者中,股下腔内治疗后踝下P1-2者保肢率差。
  • 低血清白蛋白、充血性心力衰竭、高伤口分级、踝下P1-2及腔内治疗为需大截肢的独立危险因素。

研究设计与样本

  • 回顾性分析2015至2020年因慢性肢体威胁性缺血行股下血管重建的多中心数据,共243例患者267条肢体。
  • 终点为二次大截肢,即股下血管重建后行膝上或膝下截肢。

主要发现

  • 二次大截肢组旁路手术14条(25.5%)vs 保肢组120条(56.6%)(P<0.01)。
  • 二次大截肢组腔内治疗41条(74.5%)vs 保肢组92条(43.4%)(P<0.01)。
  • 二次大截肢组平均血清白蛋白3.0±0.6 g/dL vs 保肢组3.4±0.5 g/dL(P<0.01)。
  • 二次大截肢组充血性心力衰竭36.4% vs 保肢组14.2%(P<0.01)。
  • 踝下P0、P1、P2在二次大截肢组分别为4条(7.3%)、37条(67.3%)、14条(25.5%),保肢组分别为58条(27.4%)、140条(66.0%)、14条(6.6%)(P<0.01)。

关键数值与推荐

  • 多因素分析:血清白蛋白HR 0.56(95%CI 0.36-0.89,P=0.01)。
  • 高血压HR 0.39(95%CI 0.21-0.75,P<0.01)。
  • 充血性心力衰竭HR 2.10(95%CI 1.09-4.05,P=0.03)。
  • 伤口分级HR 1.72(95%CI 1.03-2.88,P=0.04)。
  • 踝下P HR 2.08(95%CI 1.27-3.42,P<0.01);腔内治疗HR 3.31(95%CI 1.77-6.18,P<0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To evaluate limb salvage outcomes and risk factors for major amputation in chronic limb-threatening ischemia (CLTI) patients classified as stage 4 per the wound, ischemia, and foot infection (WIfI) classification following infrainguinal revascularization. METHODS: We retrospectively analyzed multicenter data of patients who had undergone infrainguinal revascularization for CLTI between 2015 and 2020. The endpoint was secondary major amputation defined as an above- or below-knee amputation following infrainguinal revascularization. RESULTS: We analyzed 243 patients with CLTI and 267 limbs. Bypass surgery was performed in 14 (25.5%) and 120 (56.6%) limbs from the secondary major amputation and limb salvage groups, respectively (P < 0.01). Endovascular therapy (EVT) was performed in 41 limbs (74.5%) in the secondary major amputation group and 92 limbs (43.4%) in the limb salvage group (P < 0.01). The average serum albumin levels were 3.0 ± 0.6 and 3.4 ± 0.5 g/dL in the secondary major amputation and limb salvage groups, respectively (P < 0.01). The percentage of congestive heart failure (CHF) was 36.4% and 14.2% in secondary major amputation and limb salvage groups, respectively (P < 0.01). The number of limbs with infra-malleolar (IM) P0, P1, and P2 were 4 (7.3%), 37 (67.3%), and 14 (25.5%), respectively, in the secondary major amputation group and 58 (27.4%), 140 (66.0%), and 14 (6.6%), respectively, in the limb salvage group (P < 0.01). Limb salvage rates at 1 year were 91.0% and 68.6% in the bypass and EVT groups, respectively (P < 0.01). Limb salvage rates at 1 year in patients with IM P0, P1, and P2 were 91.8%, 79.9%, and 53.1%, respectively (P < 0.01). Multivariate analysis revealed that serum albumin level [hazard ratio (HR), 0.56; 95% confidence interval (CI), 0.36-0.89; P = 0.01], hypertension (HR, 0.39; 95% CI, 0.21-0.75; P < 0.01), CHF (HR, 2.10; 95% CI, 1.09-4.05; P = 0.03), wound grade (HR, 1.72; 95% CI, 1.03-2.88; P = 0.04), IM P (HR, 2.08; 95% CI, 1.27-3.42; P < 0.01), and EVT (HR, 3.31; 95% CI, 1.77-6.18; P < 0.01) as independent risk factors for secondary major amputation being required. CONCLUSIONS: Among CLTI patients with WIfI stage 4, the limb salvage rate was poor in those with IM P1-2 following infrainguinal EVT. Low serum albumin levels, CHF, high wound grade, IM P1-2, and EVT were independent risk factors for CLTI patients requiring major amputation.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Morisaki K, Guntani A, Matsuda D, et al. Risk Factors for Major Amputation in Chronic Limb-Threatening Ischemia Patients Classified as Wound, Ischemia, and Foot Infection Stage 4 following Infrainguinal Revascularization. Ann Vasc Surg. 2023. PMID: 36870562. doi:10.1016/j.avsg.2023.02.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。